Monopar Announces Publication Demonstrating Potential Utility of MNPR-101 as an Imaging Agent to Improve Surgical Outcomes in Bladder Cancer
Go back to Monopar Announces Publication Demonstrating Potential Utility of MNPR-101 as an Imaging Agent to Improve Surgical Outcomes in Bladder Cancer(NASDAQ: MNPR) | Delayed: 0.65 +0.02 (3.17%) | |||||
---|---|---|---|---|---|---|
Previous Close | $0.63 | 52 Week High | $ | |||
Open | $0.62 | 52 Week Low | $ | |||
Day High | $0.66 | P/E | N/A | |||
Day Low | $0.61 | EPS | $ | |||
Volume | 85,910 |